hydroxyurea and deferiprone

hydroxyurea has been researched along with deferiprone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Datta, S1
Koussa, S; Sheikh-Taha, M; Taher, A1
Ghosh, K1

Other Studies

4 other study(ies) available for hydroxyurea and deferiprone

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Treatment of thalassoemia--the current scenario.
    Journal of the Indian Medical Association, 2002, Volume: 100, Issue:2

    Topics: Azacitidine; Bone Marrow Transplantation; Deferiprone; Fetal Hemoglobin; Genetic Therapy; Humans; Hydroxyurea; Iron Chelating Agents; Pyridones; Thalassemia

2002
Isolated thrombocytopenia associated with hydroxyurea/deferiprone (L1) therapy in a sickle beta thalassemia patient.
    Haematologica, 2006, Volume: 91, Issue:6 Suppl

    Topics: Adult; Antisickling Agents; beta-Thalassemia; Deferiprone; Drug Therapy, Combination; Humans; Hydroxyurea; Iron Chelating Agents; Male; Platelet Count; Pyridones; Thrombocytopenia

2006
Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
    The Indian journal of medical research, 2018, Volume: 148, Issue:4

    Topics: Animals; beta-Thalassemia; Chelating Agents; Deferiprone; Deferoxamine; Humans; Hydroxyurea; Iron Overload; Myelodysplastic Syndromes; Transfusion Reaction

2018